Viewing Study NCT04825860


Ignite Creation Date: 2025-12-25 @ 2:07 AM
Ignite Modification Date: 2025-12-27 @ 10:06 AM
Study NCT ID: NCT04825860
Status: TERMINATED
Last Update Posted: 2024-03-15
First Post: 2021-03-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension Phase
Sponsor: Sumitomo Pharma Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module